Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 497

1.

Are antioxidants useful for treating skeletal muscle atrophy?

Bonetto A, Penna F, Muscaritoli M, Minero VG, Rossi Fanelli F, Baccino FM, Costelli P.

Free Radic Biol Med. 2009 Oct 1;47(7):906-16. doi: 10.1016/j.freeradbiomed.2009.07.002. Epub 2009 Jul 8. Review.

PMID:
19591922
2.

Comparison of inhibitors of superoxide generation in vascular smooth muscle cells.

Luo Z, Chen Y, Chen S, Welch WJ, Andresen BT, Jose PA, Wilcox CS.

Br J Pharmacol. 2009 Jul;157(6):935-43. doi: 10.1111/j.1476-5381.2009.00259.x. Epub 2009 May 18.

3.

The growth factor midkine regulates the renin-angiotensin system in mice.

Hobo A, Yuzawa Y, Kosugi T, Kato N, Asai N, Sato W, Maruyama S, Ito Y, Kobori H, Ikematsu S, Nishiyama A, Matsuo S, Kadomatsu K.

J Clin Invest. 2009 Jun;119(6):1616-25. doi: 10.1172/JCI37249. Epub 2009 May 18.

4.

Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL.

Ebenezer PJ, Mariappan N, Elks CM, Haque M, Francis J.

Obesity (Silver Spring). 2009 Nov;17(11):1994-2002. doi: 10.1038/oby.2009.137. Epub 2009 May 7.

5.

Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase.

Durrant JR, Seals DR, Connell ML, Russell MJ, Lawson BR, Folian BJ, Donato AJ, Lesniewski LA.

J Physiol. 2009 Jul 1;587(Pt 13):3271-85. doi: 10.1113/jphysiol.2009.169771. Epub 2009 May 5.

6.

Metabolic syndrome and oxidative stress.

Ando K, Fujita T.

Free Radic Biol Med. 2009 Aug 1;47(3):213-8. doi: 10.1016/j.freeradbiomed.2009.04.030. Epub 2009 May 3. Review.

PMID:
19409982
7.

Tempol reduces bacterial translocation after ischemia/reperfusion injury in a rat model of superior mesenteric artery occlusion.

Berber I, Aydin C, Cevahir N, Yenisey C, Gumrukcu G, Kocbil G, Tellioglu G, Tekin K.

Surg Today. 2009;39(5):407-13. doi: 10.1007/s00595-008-3900-x. Epub 2009 Apr 30.

PMID:
19408078
8.

Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging.

Modrick ML, Didion SP, Sigmund CD, Faraci FM.

Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1914-9. doi: 10.1152/ajpheart.00300.2009. Epub 2009 Apr 24.

9.

Protective effect of extracellular superoxide dismutase on endothelial function during aging.

Lund DD, Chu Y, Miller JD, Heistad DD.

Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1920-5. doi: 10.1152/ajpheart.01342.2008. Epub 2009 Apr 17.

10.

Effect of chronic antioxidant therapy with superoxide dismutase-mimetic drug, tempol, on progression of renal disease in rats with renal mass reduction.

Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B.

Nephron Exp Nephrol. 2009;112(1):e31-42. doi: 10.1159/000210577. Epub 2009 Apr 3.

PMID:
19342872
12.

Novel approaches to improving endothelium-dependent nitric oxide-mediated vasodilatation.

Simonsen U, Rodriguez-Rodriguez R, Dalsgaard T, Buus NH, Stankevicius E.

Pharmacol Rep. 2009 Jan-Feb;61(1):105-15. Review.

13.

ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide.

Sharma M, Zhou Z, Miura H, Papapetropoulos A, McCarthy ET, Sharma R, Savin VJ, Lianos EA.

Am J Physiol Renal Physiol. 2009 Jun;296(6):F1386-95. doi: 10.1152/ajprenal.90369.2008. Epub 2009 Mar 18.

14.

Genotoxicity of the neurotransmitter dopamine in vitro.

Stopper H, Schupp N, Fazeli G, Dietel B, Queisser N, Walitza S, Gerlach M.

Toxicol In Vitro. 2009 Jun;23(4):640-6. doi: 10.1016/j.tiv.2009.03.001. Epub 2009 Mar 12.

PMID:
19285549
15.

The effect of tempol on endothelium-dependent vasodilatation and blood pressure.

Simonsen U, Christensen FH, Buus NH.

Pharmacol Ther. 2009 May;122(2):109-24. doi: 10.1016/j.pharmthera.2009.02.002. Epub 2009 Mar 5. Review.

PMID:
19268689
16.

Superoxide radicals increase transforming growth factor-beta1 and collagen release from human lung fibroblasts via cellular influx through chloride channels.

Qi S, den Hartog GJ, Bast A.

Toxicol Appl Pharmacol. 2009 May 15;237(1):111-8. doi: 10.1016/j.taap.2009.02.019. Epub 2009 Mar 4.

PMID:
19268487
17.

Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II.

Yatabe J, Sanada H, Yatabe MS, Hashimoto S, Yoneda M, Felder RA, Jose PA, Watanabe T.

Am J Physiol Renal Physiol. 2009 May;296(5):F1052-60. doi: 10.1152/ajprenal.00580.2007. Epub 2009 Mar 4.

18.

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension.

Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Tanus-Santos JE.

Free Radic Biol Med. 2009 May 1;46(9):1298-307. doi: 10.1016/j.freeradbiomed.2009.02.011. Epub 2009 Feb 25.

PMID:
19248829
19.

Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats.

Wei Y, Clark SE, Thyfault JP, Uptergrove GM, Li W, Whaley-Connell AT, Ferrario CM, Sowers JR, Ibdah JA.

Am J Pathol. 2009 Apr;174(4):1329-37. doi: 10.2353/ajpath.2009.080697. Epub 2009 Feb 26. Erratum in: Am J Pathol. 2009 Dec;175(6):2709-10.

20.

Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension.

Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, Francis J.

Cardiovasc Res. 2009 Jun 1;82(3):503-12. doi: 10.1093/cvr/cvp073. Epub 2009 Feb 25.

Items per page

Supplemental Content

Write to the Help Desk